Effects of Dual Inhibition of VEGF ‐A and Angpt‐2 on Angiogenesis and Lymphangiogenesis in an Alkali‐Induced Corneal Injury Model
Genes to Cells · 2025
DOI: 10.1111/gtc.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Hiroshi Kuribayashi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Retinal Biology and Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphangiogenesis, Angiopoietin-2, Vascular Endothelial Growth Factor A, Corneal Neovascularization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chugai Pharmaceutical.
Abstract (Originalsprache)
Corneal neovascularization (CNV) is frequently observed after various corneal injuries and corneal transplantation, leading to impairment of corneal transparency. Lymphangiogenesis and the inflammatory response often accompany CNV. Chemical injury is one of the most common causes of CNV, and alkali injury has been widely used as an animal model of this pathological state. We examined the effects of subconjunctival injection of an anti‐VEGFA antibody (anti‐VEGFA_ab), anti‐ANGPT2 antibody (anti‐ANGPT2_ab), and bispecific antibody against VEGFA and ANGPT2 (BsAb) in CNV using the alkali injury mouse model. The pathological indexes were examined using anterior segment optical coherence tomography (OCT) and whole‐mount immunostaining, and gene expression patterns were examined using RT‐qPCR. Treatment with anti‐VEGFA_ab, anti‐ANGPT2_ab, or BsAb did not affect the swelled thickness of the cornea; however, angiogenesis, but not lymphangiogenesis, was hampered by the treatment of either one of the antibodies. We observed an increase in the mRNA levels of Vegfa , Angpt2 , Il1b , and Cx3cr1 following alkali injury. The administration of BsAb suppressed the induction of Vegfa and Cx3cr1 . Additionally, BsAb treatment enhanced the mRNA levels of Angpt1 in this model. This study demonstrates the potential of dual VEGFA and ANGPT2 inhibition as a therapeutic strategy for CNV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Retinal Biology and Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba, Japan.
- Product Research Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
- Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Toshiro Iwagawa, Yuta Inokuchi, Takashi Miyai, Sumiko Watanabe
Förderung
- Chugai Pharmaceutical
Zitieren
APA
Kuribayashi, H., Iwagawa, T., Kadohara, S., Ohashi, H., Kawaji, C., Iida, T., Suzuki, T., Inokuchi, Y., Soeda, T., Saita, K., Aihara, M., Ebihara, N., Miyai, T., & Watanabe, S. (2025). Effects of Dual Inhibition of VEGF ‐A and Angpt‐2 on Angiogenesis and Lymphangiogenesis in an Alkali‐Induced Corneal Injury Model. Genes to Cells. https://doi.org/10.1111/gtc.70035
Vancouver
Kuribayashi H, Iwagawa T, Kadohara S, Ohashi H, Kawaji C, Iida T, et al. Effects of Dual Inhibition of VEGF ‐A and Angpt‐2 on Angiogenesis and Lymphangiogenesis in an Alkali‐Induced Corneal Injury Model. Genes to Cells. 2025. doi:10.1111/gtc.70035
BibTeX
@article{Kuribayashi2025,
author = {Kuribayashi, Hiroshi and Iwagawa, Toshiro and Kadohara, Souta and Ohashi, Hirokazu and Kawaji, Chihiro and Iida, Takeru and Suzuki, Tomoya and Inokuchi, Yuta and Soeda, Tetsuhiro and Saita, Kosuke and Aihara, Makoto and Ebihara, Nobuyuki and Miyai, Takashi and Watanabe, Sumiko},
title = {Effects of Dual Inhibition of VEGF ‐A and Angpt‐2 on Angiogenesis and Lymphangiogenesis in an Alkali‐Induced Corneal Injury Model},
journal = {Genes to Cells},
year = {2025},
doi = {10.1111/gtc.70035}
}
EUVIMED